Harrow Historical Cash Flow
| HROWL Stock | USD 25.12 0.03 0.12% |
Analysis of Harrow Health cash flow over time is an excellent tool to project Harrow Health 8625 future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 184.2 M or Total Cash From Operating Activities of 4.6 M as it is a great indicator of Harrow Health ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Harrow Health 8625 latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Harrow Health 8625 is a good buy for the upcoming year.
Harrow |
About Harrow Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Harrow balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Harrow's non-liquid assets can be easily converted into cash.
Harrow Health Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from Harrow Health's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Harrow Health 8625 current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health 8625. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.At this time, Harrow Health's End Period Cash Flow is quite stable compared to the past year. Stock Based Compensation is expected to rise to about 19 M this year, although the value of Change In Cash is projected to rise to (24.2 M).
| 2022 | 2023 | 2024 | 2025 (projected) | Depreciation | 3.7M | 12.3M | 14.2M | 14.9M | Stock Based Compensation | 8.0M | 15.7M | 18.1M | 19.0M |
Harrow Health cash flow statement Correlations
Click cells to compare fundamentals
Harrow Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Harrow Health cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Sale Purchase Of Stock | (29K) | (11M) | (876K) | (13.0M) | (11.7M) | (11.1M) | |
| Change In Cash | (648K) | 37.9M | 54.1M | (22.2M) | (25.5M) | (24.2M) | |
| Free Cash Flow | (2.1M) | (23.4M) | (6.1M) | (148.7M) | (133.8M) | (127.1M) | |
| Change In Working Capital | (6.3M) | (253K) | (5.6M) | (7.1M) | (6.4M) | (6.1M) | |
| Begin Period Cash Flow | 4.9M | 4.3M | 42.2M | 96.3M | 110.7M | 116.2M | |
| Other Cashflows From Financing Activities | (981K) | (19.2M) | (234K) | (12.6M) | (11.4M) | (10.8M) | |
| Other Non Cash Items | 815K | 677K | 9.7M | 7.4M | 8.5M | 8.9M | |
| Capital Expenditures | 994K | 28.5M | 7.8M | 152.6M | 175.4M | 184.2M | |
| Total Cash From Operating Activities | (1.1M) | 5.1M | 1.7M | 3.8M | 4.4M | 4.6M | |
| Net Income | (3.4M) | (18.0M) | (14.1M) | (24.4M) | (22.0M) | (20.9M) | |
| Total Cash From Financing Activities | 1.4M | 51.5M | 54.1M | 126.5M | 145.5M | 152.8M | |
| End Period Cash Flow | 4.3M | 42.2M | 96.3M | 74.1M | 85.2M | 89.5M | |
| Stock Based Compensation | 2.8M | 5.7M | 8.0M | 15.7M | 18.1M | 19.0M | |
| Depreciation | 2.7M | 2.4M | 3.7M | 12.3M | 14.2M | 14.9M | |
| Change To Inventory | (661K) | (255K) | (2.3M) | (4.3M) | (3.9M) | (3.7M) | |
| Change To Account Receivables | (866K) | (1.8M) | (1.9M) | (30.3M) | (27.3M) | (25.9M) | |
| Total Cashflows From Investing Activities | (1.8M) | (981K) | (18.7M) | (1.7M) | (1.6M) | (1.6M) | |
| Other Cashflows From Investing Activities | 13K | (14.1M) | 6M | (151.1M) | (136.0M) | (129.2M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health 8625. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Harrow Health 8625 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.